SecSonar.com

Galapagos N.V. (GLPG)

Galapagos N.V. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Galapagos N.V. (GLPG) is a Biotechnology company based in BE with a market capitalization of $1.9B. Revenue grew 303.5% year-over-year and free cash flow was negative at -$231.5M. This page tracks GLPG's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

BE · 704 employees · IPO Feb 27, 2012

Valuation

Valuation & price

$27.65 · as of May 26, 2026 · -26.5% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$37.62$32.16$26.69Jul 25Dec 25Jun 26Jul 7, 25$28.49Jul 9, 25$29.85Jul 11, 25$30.30Jul 15, 25$30.27Jul 17, 25$30.66Jul 21, 25$32.14Jul 23, 25$33.29Jul 25, 25$32.65Jul 29, 25$32.82Jul 31, 25$32.82Aug 4, 25$33.39Aug 6, 25$32.80Aug 8, 25$32.56Aug 12, 25$31.67Aug 14, 25$31.79Aug 18, 25$32.91Aug 20, 25$31.76Aug 22, 25$32.00Aug 27, 25$32.91Aug 29, 25$31.44Sep 3, 25$31.26Sep 5, 25$33.36Sep 9, 25$32.67Sep 11, 25$32.55Sep 15, 25$31.88Sep 17, 25$32.26Sep 19, 25$34.14Sep 23, 25$33.54Sep 25, 25$32.66Sep 29, 25$34.43Oct 1, 25$35.04Oct 3, 25$37.62Oct 7, 25$34.93Oct 9, 25$34.02Oct 13, 25$33.92Oct 16, 25$34.09Oct 20, 25$34.39Oct 22, 25$31.87Oct 24, 25$31.96Oct 28, 25$31.34Oct 30, 25$31.34Nov 3, 25$30.98Nov 5, 25$29.89Nov 7, 25$31.53Nov 11, 25$32.85Nov 13, 25$31.49Nov 17, 25$30.76Nov 19, 25$30.49Nov 21, 25$30.66Nov 25, 25$31.12Nov 28, 25$31.32Dec 2, 25$31.35Dec 5, 25$31.59Dec 9, 25$31.63Dec 11, 25$32.57Dec 15, 25$31.11Dec 17, 25$31.53Dec 19, 25$32.36Dec 23, 25$32.94Dec 26, 25$33.03Dec 30, 25$32.61Jan 2, 26$32.97Jan 6, 26$32.52Jan 8, 26$32.99Jan 12, 26$33.11Jan 14, 26$34.12Jan 16, 26$33.52Jan 21, 26$33.48Jan 23, 26$34.40Jan 28, 26$34.10Jan 30, 26$33.88Feb 3, 26$34.60Feb 5, 26$33.38Feb 9, 26$33.60Feb 11, 26$34.06Feb 13, 26$33.92Feb 18, 26$34.59Feb 20, 26$33.77Feb 24, 26$34.36Feb 26, 26$33.49Mar 2, 26$34.09Mar 4, 26$33.69Mar 6, 26$32.92Mar 10, 26$33.21Mar 12, 26$31.93Mar 16, 26$32.70Mar 19, 26$32.53Mar 23, 26$31.90Mar 25, 26$30.64Mar 27, 26$28.93Mar 31, 26$30.00Apr 2, 26$29.42Apr 7, 26$28.93Apr 9, 26$28.56Apr 13, 26$28.56Apr 15, 26$29.16Apr 17, 26$29.28Apr 21, 26$28.91Apr 23, 26$28.68Apr 27, 26$28.47Apr 29, 26$27.86May 1, 26$28.00May 5, 26$28.39May 8, 26$28.59May 12, 26$27.33May 14, 26$27.49May 18, 26$26.69May 20, 26$27.40May 22, 26$27.49May 27, 26$27.73May 29, 26$28.35Jun 2, 26$27.27Jun 4, 26$28.11Jun 8, 26$27.83Jun 10, 26$28.61Jun 12, 26$28.90Jun 16, 26$28.18Jun 18, 26$28.30Jun 23, 26$29.05Jun 29, 26$29.67
$26.6152-week range$37.62
Loading valuation history…

Fundamentals

Key fundamentals

$1.9B

Market cap

303.5%

Revenue growth (YoY)

97.3%

Gross margin

-$231.5M

Free cash flow (USD)

-$3B

Net debt

Net cash position

0.1%

Share dilution

4/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$129.5MFY 2017$127.1MFY 2018$288.8MFY 2019$834.9MFY 2020$478.1MFY 2021$484.8MFY 2022$241.2MFY 2023$239.7MFY 2024$275.6MFY 2025$1.1B
$129.5M$1.1B

Free cash flow by year

2016 → 2025

FY 2016$234.6MFY 2017$-154.5MFY 2018$-156.2MFY 2019$3.6BFY 2020$-518.7MFY 2021$-561.7MFY 2022$-537.5MFY 2023$-425.2MFY 2024$-402.1MFY 2025$-202.4M
$234.6M-$202.4M

Gross margin by year

2021 → 2025

FY 202199.7%FY 2022100.0%FY 2023100.0%FY 202487.3%FY 202597.3%
99.7%97.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: —

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

No tracked SEC signals for GLPG yet — activity appears here as filings land on EDGAR.

Questions

Frequently asked questions

What is Galapagos N.V.'s market cap?

Galapagos N.V. (GLPG) has a market capitalization of $1.9B.

What is GLPG's P/E ratio?

A meaningful P/E ratio is not available for GLPG — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

Are insiders buying GLPG stock?

SEC Form 4 filings show no open-market insider buys at Galapagos N.V. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

ABCL

AbCellera Biologics Inc.

$1.9B

BCRX

BioCryst Pharmaceuticals, Inc.

$1.9B

AAPG

Ascentage Pharma Group International

$1.9B

ADMA

ADMA Biologics, Inc.

$1.9B

SRPT

Sarepta Therapeutics, Inc.

$1.9B

ZYME

Zymeworks Inc.

$1.9B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.